(Press-News.org) COLUMBUS, Ohio - The health benefits of over-the-counter curcumin supplements might not get past your gut, but new research shows that a modified formulation of the spice releases its anti-inflammatory goodness throughout the body.
Curcumin is a naturally occurring compound found in the spice turmeric that has been used for centuries as an Ayurvedic medicine treatment for such ailments as allergies, diabetes and ulcers.
Anecdotal and scientific evidence suggests curcumin promotes health because it lowers inflammation, but it is not absorbed well by the body. Most curcumin in food or supplements stays in the gastrointestinal tract, and any portion that's absorbed is metabolized quickly.
Many research groups are testing the compound's effects on disorders ranging from colon cancer to osteoarthritis. Others, like these Ohio State University scientists, are investigating whether enabling widespread availability of curcumin's biological effects to the entire body could make it useful both therapeutically and as a daily supplement to combat disease.
"There's a reason why this compound has been used for hundreds of years in Eastern medicine. And this study suggests that we have identified a better and more effective way to deliver curcumin and know what diseases to use it for so that we can take advantage of its anti-inflammatory power," said Nicholas Young, a postdoctoral researcher in rheumatology and immunology at Ohio State and lead author of the study.
The research is published in the Nov. 4, 2014, issue of the journal PLOS ONE.
Curcumin powder was mixed with castor oil and polyethylene glycol in a process called nano-emulsion (think vinaigrette salad dressing), creating fluid teeming with microvesicles that contain curcumin. This process allows the compound to dissolve and be more easily absorbed by the gut to enter the bloodstream and tissues.
Feeding mice this curcumin-based drug shut down an acute inflammatory reaction by blocking activation of a key protein that triggers the immune response. The researchers were also the first to show that curcumin stops recruitment of specific immune cells that, when overactive, are linked to such problems as heart disease and obesity.
Young and his colleagues, including co-senior authors Lai-Chu Wu and Wael Jarjour of the Division of Rheumatology and Immunology at Ohio State's Wexner Medical Center, now want to know if curcumin in this form can counter the chronic inflammation that is linked to sickness and age-related frailty. They have started with animal studies testing nano-emulsified curcumin's ability to prevent or control inflammation in a lupus model.
"We envision that this nutraceutical could be used one day both as a daily supplement to help prevent certain diseases and as a therapeutic drug to help combat the bad inflammation observed in many diseases," Young said. "The distinction will then be in the amount given - perhaps a low dose for daily prevention and higher doses for disease suppression."
The term nutraceutical refers to foods or nutrients that provide medical or health benefits.
The curcumin delivery system was created in Ohio State's College of Pharmacy, and these researchers previously showed that concentrations of the emulsified curcumin in blood were more than 10 times higher than of curcumin powder suspended in water. From there, the researchers launched experiments in mice and cell cultures, generating artificial inflammation and comparing the effects of the nano-emulsified curcumin with the effects of curcumin powder in water or no treatment at all.
The researchers injected mice with lipopolysaccharide, a bacteria cell wall extract that stimulates an immune reaction in animals. Curcumin can target many molecules, but the research team zeroed in on NF-kB, a protein that is known to play an important role in the immune response.
In a specialized imaging machine, mice receiving plain curcumin lit up with bioluminescent signals indicating that NF-kB was actively triggering an immune response, while mice receiving nano-emulsified curcumin showed minimal signs - a 22-fold reduction - that the protein had been activated at all.
Knowing that curcumin delivered in this way could shut down NF-kB activation throughout the animals' bodies, researchers looked for further details about the compound's effects on inflammation. They found that nano-emulsified curcumin halted the recruitment of immune cells called macrophages that "eat" invading pathogens but also contribute to inflammation by secreting pro-inflammatory chemicals. And in cells isolated from human blood samples, macrophages were stopped in their tracks.
"This macrophage-specific effect of curcumin had not been described before," Young said. "Because of that finding, we propose nano-emulsified curcumin has the best potential against macrophage-associated inflammation."
Inflammation triggered by overactive macrophages has been linked to cardiovascular disease, disorders that accompany obesity, Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, diabetes and lupus-related nephritis.
INFORMATION:
This work was supported by The Ohio State University Wexner Medical Center and Comprehensive Cancer Center Support (CORE) grant from the National Institutes of Health/National Cancer Institute and funding for Ohio State's Center for Clinical and Translational Science provided by the National Center for Advancing Translational Sciences.
Additional co-authors are Michael Bruss, Mark Gardner, William Willis and Giancarlo Valiente of the Division of Rheumatology and Immunology; Xiaokui Mo of the Center for Biostatistics; and Yu Cao and Zhongfa Liu of the College of Pharmacy, all at Ohio State.
Contact: Nicholas Young, 614-293-4439; Nicholas.Young@osumc.edu
Written by Emily Caldwell, 614-292-8310; Caldwell.151@osu.edu
BOSTON - (November 6, 2014) - Mary R. Loeken, Ph.D., Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School, has discovered a molecular pathway responsible for neural tube defects in diabetic pregnancies. Her latest research findings in this pathway were published in the October issue of Diabetes.
For 20 years, scientists have known of a gene involved in neural tube defects (such as spina bifida), but until now it was not known exactly what causes this gene to malfunctions ...
The modern sequencing techniques have shown that bats can carry a bacterial species previously been shown to cause deadly human infections in USA.
When the research group of Arto Pulliainen at the Department of Biosciences, University of Helsinki, Finland, analyzed an array of bat samples from Finland and UK, one class of identified bacteria turned out to be exceptionally significant. Multilocus sequence analyses of clonal bat Bartonella isolates demonstrated that bats carry Bartonella mayotimonensis. This species has previously been shown to cause deadly human infections ...
MANHATTAN, KANSAS -- A Kansas State University psychological sciences professor is using twin studies to understand the nature versus nurture debate of the workplace: Do genetic factors or environmental factors influence employee proactivity?
His answer: The interaction between the genetic and environmental factors determines why some employees are more proactive than others.
"It's more like nature and nurture rather than nature versus nurture," said Wendong Li, assistant professor of psychological sciences in the College of Arts & Sciences. "It is the reciprocal relationship ...
For decades, scientists have been perfecting models of how contagions spread, but newly published research takes the first steps into building a model that includes the loop linking individual human behavior and the behavior of the epidemic itself.
The first results of the highly complex modeling led by researchers at the New York University Polytechnic School of Engineering were recently spotlighted as "brilliant research" by the American Physical Society.
Eventually, the team hopes the model will more accurately predict who should be vaccinated and isolated first ...
By combining projections of climate change, emissions reductions and changes in land use across the USA, an international research team estimate that by 2050, cumulative exposure to ozone during the summer will be high enough to damage vegetation.
Although the research findings - published in Atmospheric Chemistry and Physics Discussions - focus on the impact in the USA, they raise wider concerns for global air quality, according to lead researcher Dr Maria Val Martin, from the University of Sheffield's Faculty of Engineering
"Modelling future air quality is very complex, ...
The dreaded scratch or puncture test is the most common way of assessing allergic reactions to as many as 40 different substances at once. But because the test involves needles that prick multiple points along the skin's surface, it's a particularly high-stress examination for children -- and their understandably anxious parents.
A new study by Tel Aviv University researchers provides the first quantitative analysis of the role of "medical clowns" in assuaging the anxiety and pain felt by children undergoing allergy tests. The research, published in Allergy, was conducted ...
Far too many "teachable moments" are lost in a doctor's office during which young adults with hypertension could have learned how to reduce their blood pressure. In fact, only one in every two hypertensive young Americans does in fact receive such advice and guidance from a healthcare provider within a year from being diagnosed, says Heather M. Johnson of the University of Wisconsin School of Medicine and Public Health in the US. She led a study which examined how regularly such education is provided and documented by one of the ten largest physician practice groups in ...
A major new Series on health and ageing, published in The Lancet, warns that unless health systems find effective strategies to address the problems faced by an ageing world population, the growing burden of chronic disease will greatly affect the quality of life of older people. As people across the world live longer, soaring levels of chronic illness and diminished wellbeing are poised to become a major global public health challenge.
Worldwide, life expectancy of older people continues to rise. By 2020, for the first time in history, the number of people aged 60 years ...
A car powered by its own body panels could soon be driving on our roads after a breakthrough in nanotechnology research by a QUT team.
Researchers have developed lightweight "supercapacitors" that can be combined with regular batteries to dramatically boost the power of an electric car.
The discovery was made by Postdoctoral Research Fellow Dr Jinzhang Liu, Professor Nunzio Motta and PhD researcher Marco Notarianni, from QUT's Science and Engineering Faculty - Institute for Future Environments, and PhD researcher Francesca Mirri and Professor Matteo Pasquali, from Rice ...
Toronto, ON - For most cancer patients, primary tumours are often not the most deadly. Instead, it is the metastatic tumours - tumours that spread from their original location to other parts of the body - that are the cause of most cancer deaths.
The catalysts behind the formation of these deadly metastatic tumours are believed to be cancer cells that are launched into the bloodstream from the original site of the cancer. Researchers are very interested in leveraging these circulating tumour cells, or CTCs, which have the potential to allow the properties of a tumour ...
